This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
AI and the Global IP System We need a worldwide intellectual property (IP) structure that encourages innovation and invention if we are to benefit from generative AI. Specifically, artificial intelligence (AI) technologies have opened up new avenues for invention that only minimally entail human intervention.
The Opponent, Avl List GmbH, challenged the patent's validity based on several grounds, including prior public use as evidenced by a user manual describing the invention. The OD had found the user manual not to be prior art, and so had not fully considered the novelty and inventive step of the claim invention in view of the manual.
Kaijet highlights the narrowness of the pre-filing grace period (safe harbor) provision under the America Invents Act (AIA) and serves as a reminder that there are a number of patents that would have been valid under the pre-AIA patent system may no longer be valid under the current law. 2023-1336 (Fed. Sanho Corp. July 31, 2024).
Another source of confusion is the divergent approaches of the UK courts and the EPO with respect to the test for the evidence standard in sufficiency and inventive step analysis. Plausibility demystified - a review of EPO case law before G 2/21 G 2/21: Is the technical effect embodied by the invention as originally disclosed?
All the creations of the human minds such as designs, inventions, artistic works, names, symbols, etc. Patents Patent protects new inventions that features technological advancements or economic significance or both and are capable of being used in the industry. Key Features: The invention must be new, non-obvious, and have utility.
2023-1336 (Fed. July 31, 2024) In our Case of the Week, the Federal Circuit held that the private but non-confidential sale of thousands of laptop ports did not count as a “public disclosure” of the inventions embodied therein. Sanho Corp. Kaijet Technology International Limited Inc., By: Schwabe, Williamson & Wyatt PC
Most employee confidentiality and similar agreements contain an assignment of invention provision. These typically provide that all employee inventions created during the employee’s employment are assigned to or owned by the company.
On September 15, 2023, New York Governor Kathy Hochul signed a law that made dramatic changes to the enforceability of invention assignment provisions in employment agreements and likely in related agreements including offer letters and Confidentiality, Information and Invention Assignment Agreements (CIIAAs).
As 2023 commences, it’s time for companies to review and take stock of their intellectual property assets. A company should always be aware of any new inventions under development, and it is good practice to investigate the status of any inventions developed by company employees during the past year.
Here is our recap of last week’s top IP developments including summaries of the posts on IPO’s patent application rejection of HIV drug Dolutegravir, another judgement in the long-running Section 3(k) saga, this time on the patentability of business methods and the DHC IPD’s Annual Report 2023-24. Anything we are missing out on?
Workshop on ‘Patent Opposition in the Pharmaceutical Field’ [Kochi, April 24-28] We are pleased to announce that the Inter-University Centre for IPR Studies (IUCIPRS), CUSAT, and Third World Network are jointly organizing the 4th edition of their workshop on ‘Patent Opposition in the Pharmaceutical Field’ between April 24-28, 2023.
AI’s capacity to generate content, inventions, and insights from this data intensifies concerns, not only about ownership but also about copyright and trade secrets. Through a bunch of IP laws like copyright, patent, and trade secrets, expressions, innovations, and confidential information are respectively protected.
It involves several IP rights, some of which overlap in some cases: copyright, trademarks, patents, trade secrets/confidential information, and the right of publicity (and similar rights with different names). EU (CDSM arts 3-4; obligation concerning sufficiently detailed summary in June 2023 draft of AI Act) d. Fair dealing c.
Do You Need Multiple Patents for a Single, Multi-Use Invention? If your invention has multiple innovations or components, you may be wondering whether to file separate patent applications for each innovation or file one application for the entire invention. Does the single invention have different uses?
Case: Coolulu Sports Private Limited vs Union Of India on 5 April, 2023 (Karnataka High Court) Image from here The writ petition was filed against the order of the Regional Director, Corporate Affairs directing the petitioner to change its name for being similar to the trademark of the respondent no. 2 (Lulu Mall).
In a cautionary tale for inventors participating in trade shows and other non-confidential presentations, on February 15, 2023, the U.S. By: Rothwell, Figg, Ernst & Manbeck, P.C.
The legal frameworks surrounding IP, including the patents, trademarks, copyrights, and business enigmas bargain the startups the aptitude to protect their intellectual assets, ensuring their thoughts and the inventions are lawfully saved from unlawful use or imitation. The inventions of any startups are protected through the Copyright laws.
As 2023 commences, it’s time for companies to review and take stock of their intellectual property assets. A company should always be aware of any new inventions under development, and it is good practice to investigate the status of any inventions developed by company employees during the past year.
2021-2246 ] (February 15, 2023), the Federal Circuit affirmed summary judgment that the asserted claims of U.S. Minerva did not disclose the devices under any confidentiality obligations, despite the commercial nature of the event. Second, Minerva argued that there was no disclosure of the claimed invention. Hologic, Inc.,
However, there was also no express or implied obligation of confidentiality binding individuals who attended. In that Motionless Keyboard , the alleged prior use involved displaying the invention (a keyboard). In distinguishing these cases, the Federal Circuit looked to the purpose of the invention. Microsoft Corp.,
By David Hricik, Mercer Law School Noted below, Akin Gump had sued a former vendor, Xcential, arguing that its lawyers had invented what Xcential had sought to patent. 2023), which involved a firm’s admitted use of text from one patent application in an application for another client in closely related cases. The order is here.
The Ibrutinib Patent Dispute Adding another chapter to the long-standing legal dispute concerning the Leukaemia medication Imbruvica (API Ibrutinib), the Delhi High Court on December 21, 2023, upheld the IPAB order setting aside the post-grant rejection of the Ibrutinib patent. However, the Court rejected these arguments.
Formula One can be perceived as an epicentre of inventions and innovations, making intellectual property indispensable in the sport. The Confidential information, which may be sold or licensed, is a Trade Secret and forms a part of Intellectual Property Rights. WHAT DO INTERNATIONAL CONVENTIONS SAY? 39 of the TRIPS agreement.
I recounted how AstraZeneca claims that sale of Dapagliflozin violates not one but two of its patents: the genus which expired in October 2020, and the species which specifically disclosed the drug and is set to expire in 2023. News from India.
Introduction A “patent” is a right granted by a state to an inventor for a fixed period i.e., 20 years in India in exchange for the disclosure of the invention. The fundamental patentability criteria are universal namely: novelty, inventive step, non-obviousness and industrial applicability.
Image from here The World IP Indicator 2023 highlights India’s progress in the global patent race. 3 Landscape on Patenting Biotechnology Inventions in India How does Section 3 of the Indian Patent Act interact with biotech inventions? Please drop a comment and let us know. But does this guarantee innovation?
In 2023, the International Trade Commission (ITC) ruled in Masimo’s favor and ordered Apple stop important and selling its leading Series 9 and Ultra 2 Apple Watches. However, a December 27 2023 emergency order from the Federal Circuit has temporarily stayed that exclusion order pending further briefing in the case.
Moreover, IP rights are inherently territorial, creating problems for IP owners who use cloud computing, such as their patented inventions being used or infringed in multiple locations without their consent or knowledge. 2023) IP issues in cloud computing, Intellectual Property, IPR & Corporate Law Firm Chennai, Bengaluru.
Case Summaries Ajay Polymers vs Vibhor Aggarwal Trading As Feenulax Hitech Amritsar on 7 December, 2023 (Delhi High Court) The plaintiff filed a suit against the defendant alleging trademark infringement over their use of “UNNATRAVINDRA” for similar pipes and pipeline products. M/S Loreal S.A
The USPTO begins with a review of the duties of candor and good faith, confidentiality, and export regulations. terms of use, privacy policies, disclosure risks) and applicable regulatory standards to prevent unintentional leaks, to protect confidential client information, and for compliance with USPTO Rules and applicable laws.
The general aim of the expert evidence, either court appointed or bench appointed, is to ‘educate the court’ and ‘assist the judge’ which in the realm of IP could be questions such as ‘invalidity of an inventive step’, ‘insufficiency of an inventive step’ or infringement etc. and Ors (2023, Petition Withdrawn) Justice Pratibha M.
In this (delayed yet relevant) post, we will discuss the bizarre ongoing Trastuzumab and Bevacizumab litigation before the DHC, focussing on the September 11, 2023 joint judgement passed in two connected cases (Roche versus DCGI, and versus Cadila, respectively).
The decision highlighted the Controller’s duty to consider existing knowledge and the inventive step properly. ” The Deputy Controller of Patents cited lack of novelty and inventive step (Section 2(1)(ja)) and non-compliance with Section 59(1).
A quick glance at last week – Madras HC accepts a US District Court’s Letter Rogatory to furnish confidential information, a look at Functional Fallacies in Thomson Reuters vs Ross Intelligence and many more. Interestingly, Judge Bibas has changed his position from his initial 2023 opinion in the same case.
Softgel: The Errors of Comity The Madras High Court accepted a Letter Rogatory from The US District Court in Delaware directing India-based Softgel Healthcare to furnish confidential information to the US Court. Interestingly, Judge Bibas has changed his position from his initial 2023 opinion in the same case.
In our AI-driven world, we might rephrase it as: If we share our secrets with an AI language model like ChatGPT, but the information remains unused, does it count as trade secret disclosure or public disclosure of an invention? Spoiler alert: sharing invention details with ChatGPT does not count as public use or on sale. enablement).
In our AI-driven world, we might rephrase it as: If we share our secrets with an AI language model like ChatGPT, but the information remains unused, does it count as trade secret disclosure or public disclosure of an invention? Spoiler alert: sharing invention details with ChatGPT does not count as public use or on sale. enablement).
In our AI-driven world, we might rephrase it as: If we share our secrets with an AI language model like ChatGPT, but the information remains unused, does it count as trade secret disclosure or public disclosure of an invention? Spoiler alert: sharing invention details with ChatGPT does not count as public use or on sale. enablement).
Nirtech – Analysing the Claim of Breach of Confidential Information Image from here. Ex-employees using confidential information acquired from the former employer! Nirtech on protecting confidential information. on 19 April, 2023 (Delhi District Court) image from here. on 21 April, 2023 (Delhi High Court) Image from here.
From an in-depth discussion on the terms of copyright and translations in India to the recent UK Supreme Court’s order regarding the patentability of inventions by an AI, we had some engaging posts on this blog this week. The Court directed the NBA to determine whether the invention relates to biological resource with a reasoned order.
As 2023 comes to an end, in line with our annual tradition, we take stock of the top IP developments that occurred this year. We have also included a list of other notable IP developments of 2023. The judgement was passed in October 2022, but was uploaded in September 2023 on the High Court’s website. A special thanks to Mr. G.
Read : David Boundy, What Every Patent and Trademark Lawyer Should Understand About the MPEP, TMEP, and Other Guidance: How to Use (and Defend Against) the MPEP to be a Better Advocate , 2023 Patently-O Patent Law Journal 1 (2023) ( Boundy.2021.HowToUseGuidance HowToUseGuidance ). Prior Patently-O Patent L.J. GrayLeCozDuan ).
No earlier than July 31, 2023 per settlement. No earlier than November 20, 2023 per settlement. . No earlier than June 30, 2023 per settlement. No earlier than September 30, 2023 per settlement. No earlier than July 1, 2023 per settlement. No earlier than January 31, 2023 per settlement. January 2021.
No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. . No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. No earlier than 2023 per settlement. Time from BLA Acceptance to Approval 3.
We organize all of the trending information in your field so you don't have to. Join 9,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content